8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive ... #Management #Cardiology
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
Diagnostic Algorithm ... for Treatment of Iron ... Patients With Heart Failure ... #Deficiency #Management ... #HFrEF #sCHF #HeartFailure
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... , haemoglobin; HFrEF ... #Deficiency #Management ... #Diagnosis #HFrEF ... #sCHF #HeartFailure
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
in Heart Failure ... Guidelines: • ACC ... patients with HFrEF ... #HFrEF #heartfailure ... #diagnosis #management
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... of Heart Failure ... Society of America #HFrEF ... #CHF #guideline ... cardiology #treatment #algorithm
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... /ambcarerx #CHF ... #HFrEF #Pharmacology
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
hospitalization for the management ... Spironolactone #HFpEF ... #dCHF #Cardiology ... #EBM #VisualAbstract ... #Trial